OpenAI CEO Sam Altman rethinks Trump

Musk clashes with OpenAI CEO Sam Altman over Trump-supported Stargate AI data center project
Elon Musk is clashing with OpenAI CEO Sam Altman over the Stargate artificial intelligence infrastructure project touted by President Donald Trump, the latest in a feud between the two tech billionaires that started on OpenAI's board and is now testing Musk's influence with the new president.
Trump had phone call with OpenAI's Sam Altman last week about AI infrastructure
President Donald Trump spoke with OpenAI CEO Sam Altman by phone Friday, ahead of the AI infrastructure announcement, CNBC has learned.
After Trump's mega $500 billion AI investment, OpenAI CEO Sam Altman's big confession amid rivalry with Elon Musk
The top tech companies Tuesday announced that they will create a new company, called Stargate, to grow artificial intelligence infrastructure in the United States. OpenAI CEO Sam Altman has shown support for Donald Trump,
Why Elon Musk and Sam Altman sparring over Donald Trump backed $500 billion Stargate project? Key thing to know
Elon Musk and OpenAI CEO Sam Altman are in a dispute over the Stargate AI project proposed by Donald Trump, which aims to invest $500 billion in AI infrastructure. Musk questions the necessity of the funding while Altman defends the project as beneficial for the country.
Elon Musk and Sam Altman spar over Trump’s Stargate AI project
A public feud erupts between Elon Musk and OpenAI CEO Sam Altman regarding Trump's Stargate AI initiative, questioning investment credibility and national interest
Sam Altman Says He's Changed His Mind on Donald Trump
Sam Altman, the CEO of OpenAI, has announced a shift in his previously critical perspective on President Donald Trump. Newsweek has contacted OpenAI and the White House for comment via email. Altman's announcement came one day after Trump named OpenAI,
Does Sam Altman Need Donald Trump, or Is It the Other Way Around?
At a press conference capping his first full day back in the White House, Donald Trump stood beside three of the most influential executives in the world—Sam Altman of OpenAI, Larry Ellison of Oracle,
OpenAI CEO Sam Altman rethinks Donald Trump: 'Incredible for US in many ways'
The OpenAI CEO stated that though he didn't agree with the President on everything, he would be "incredible" for the country
Sam Altman Doesn’t Actually Need Trump
At a press conference capping his first full day back in the White House, Donald Trump stood beside three of the most ...
Altman Tells ChatGPT Fans To Stop The Hype On AGI & Superintelligence
OpenAI CEO Sam Altman is battling rumors surrounding superintelligence and AGI (artificial general intelligence). Is ChatGPT ...
Sam Altman predicts artificial superintelligence (AGI) will happen this year
Alan Thompson, an expert in artificial intelligence and former chairman of Mensa International, runs the Conservative ...
OpenAI exec responds to Musk, Altman trading barbs over Stargate: We're at 'the tip of the iceberg'
OpenAI CFO Sarah Friar, who's very "close" to the Stargate deal, confirms the company's ability to financially back the AI project and urges Elon Musk to compete for "the right things." ...
Sam Altman says the kid he’s expecting soon will never be smarter than AI, but thinks this ability will be valuable
"And of course it's smarter than us. Of course, it can do things we can't, but also who really cares? I think it's only weird ...
Wyoming News21h
Musk clashes with Altman over Trump-supported Stargate AI data center project
Elon Musk is clashing with OpenAI CEO Sam Altman over the Stargate artificial intelligence infrastructure project touted by ...
eWeek2d
Sam Altman’s AI Briefing: Super-Agents To Revolutionize Software, Finance, and More
OpenAI CEO Sam Altman will brief U.S. officials on super-agents—AI systems set to revolutionize software development, finance ...
Sam Altman-backed Retro Biosciences to raise $1bn for longevity mission
Retro Biosciences is raising a $1bn round to fund the artificial intelligence-powered biotech’s mission to increase human lifespan by a decade, starting by getting its first drug into trials this year ...